Spinal Fusion

VySpine has announced FDA 510(k) clearance of its UniVy OsteoVy-Ti NanoVy-HA cervical intervertebral body fusion system, according to a press release.

Implanet has announced FDA 510(k) clearance of its Squale anterior cervical cage, according to a company press release.

The FDA issued a final rule to classify spinal spheres for use in intervertebral fusion procedures into class III assignment and to require the filing of premarket approval applications for these products.

Projections showed a decreasing and aging working population along with increasing demand and costs of posterior spinal fusion may challenge the German health care system.

According to published results, skip anterior cervical corpectomy and fusion is safe and effective for patients with cervical pathology who require multilevel cervical decompression and correction of cervical alignment.

Providence Medical Technology has announced FDA clearance of the Cavux facet fixation system for a new indication in the treatment of cervical pseudarthrosis, according to a press release.

Although wearable technology has been used for research in orthopedics for several decades, its use for tracking patient outcomes has been in constant flux.

OsteoCentric Technologies has announced FDA 510(k) clearances for its OsteoCentric pedicle screw fastener system and its Integrity-SI spinal fusion system, according to a company press release.

Theragen has announced the issuance of a second U.S. patent for its ActaStim-S, a wearable and app-compatible postoperative bone growth stimulator for patients undergoing spinal fusion, according to a release.

Results showed patients with adolescent idiopathic scoliosis who were released to unrestricted activity at 4 to 8 weeks after posterior spinal fusion had high return to sport rates with a rapid return to baseline performance levels.